AI in Drug Discovery and Development Market Gains Momentum, Attracts Strategic Investments with 18.5% CAGR (2025-2033) | Top Companies 2025 - Alphabet (Google DeepMind), Atomwise Inc., BenevolentAI, BioMap, Among others.

"The Global AI in drug discovery and development market reached US$ 6.24 billion in 2024 and is expected to reach US$ 34.05 billion by 2033, growing at a CAGR of 18.5% during the forecast period 2025-2033." As per DataM intelligence research report

As per our analysis The AI in Drug Discovery & Development market is accelerating as pharmaceutical and biotech firms adopt machine learning and generative AI to design new compounds, repurpose existing drugs, and streamline preclinical testing. Applications in oncology dominate, but infectious diseases and rare conditions are emerging as high-growth segments. Increasing collaborations between pharma giants, AI startups, and academic labs are fueling innovation and shortening timelines to clinical trials. North America leads in infrastructure and funding, while Asia-Pacific especially China and India is expanding rapidly with supportive policies and rising biotech talent. Integration of big data, genomics, and cloud computing is enhancing accuracy and productivity across R&D pipelines. As costs, timelines, and global healthcare needs escalate, this market is revolutionizing drug discovery with speed, precision, and scalability.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/ai-in-drug-discovery-and-development-market?sp

AI in Drug Discovery and Development Market Dynamics:

The AI in drug discovery and development market is driven by the need to accelerate R&D timelines, reduce costs, and improve the success rate of new therapies. AI enables rapid analysis of vast biomedical datasets, identifying drug targets and predicting molecular behavior with high precision. Pharmaceutical companies are leveraging machine learning to streamline lead identification and optimize clinical trial designs. The growing volume of genomic and clinical data further enhances AI's utility in personalized medicine. Rising collaboration between tech firms and biotech companies is fostering innovation. Regulatory support for AI-driven research is also encouraging adoption.

Market growth is supported by advancements in deep learning, natural language processing, and AI-powered simulation tools that enhance drug candidate screening. AI shortens discovery cycles and enables real-time decision-making across preclinical and clinical stages. Increased investment from venture capital and pharmaceutical giants is expanding the AI drug pipeline. Startups and established players are launching platforms to predict drug efficacy and toxicity. Integration with cloud computing and high-performance computing systems is boosting scalability. As AI continues to prove its value, it is becoming an indispensable tool in next-generation drug development.

AI in Drug Discovery and Development Market: Recent Industry Developments

✅In July 2025 Executives confirmed that Isomorphic Labs is "very close" to initiating human trials of AI-designed drugs, marking a nearly historic approaching milestone

✅In April 2025 Its drug Rentosertib, designed entirely via generative AI (target and compound), received its official USAN name-marking the first such AI drug to be so recognized

Strategic Players Driving the AI in Drug Discovery and Development Market Forward:

Alphabet (Google DeepMind), Atomwise Inc., BenevolentAI, BioMap, BioSymetrics, DEEP Genomics, Euretos, Exscientia, IBM, and Iktos. Among others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/ai-in-drug-discovery-and-development-market?sp

Research Methodology:
The global AI in Drug Discovery and Development Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the AI in Drug Discovery and Development Market:

♦By Technology: Machine Learning, Natural Language Processing, Generative AI, and Others

♦By Application: Target Discovery & Validation, Hit Discovery & Virtual Screening, Screening, Hit-to-Lead, Lead Optimization, Pre-Clinical Testing, Clinical Trials, and Others

Regional Analysis for AI in Drug Discovery and Development Market:

The AI in Drug Discovery and Development market is rapidly expanding due to rising demand for faster, cost-effective drug development. North America, particularly the U.S., leads with strong AI startups, pharmaceutical giants, and advanced computing infrastructure. Europe, including the U.K., Germany, and Switzerland, shows solid growth supported by research collaborations and regulatory openness. Asia-Pacific, especially China, India, and Japan, is emerging quickly with government-backed AI initiatives and growing biotech sectors. South America, led by Brazil, is gradually embracing AI in preclinical and research phases. The Middle East & Africa are showing early potential, supported by investments in healthcare innovation and digital transformation.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=ai-in-drug-discovery-and-development-market?sp

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.